ValuationViz

LGND fund manager activity

Ligand Pharmaceuticals Incorporated · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q3 2013 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed121,440$38,386,0260.01%Aug 4, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed3,610$1,141,0850.00%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Ken Fisher - Fisher Asset ManagementTrimmed127,994$25,554,0380.01%May 5, 2026
Joel Greenblatt - Gotham Asset ManagementTrimmed4,172$832,9400.00%May 15, 2026

Older quarters